Cover Image

Correction: A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation of Mass Drug Administration.

Saved in:

Bibliographic Details
Format:	Book
Published:	Public Library of Science (PLoS), 2014-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correction: A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation of Mass Drug Administration
Published: (2014)

A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
by: Ramakrishna U Rao, et al.
Published: (2014)

Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
by: Ramakrishna U Rao, et al.
Published: (2017)

Lymphatic Filariasis in Sri Lanka
by: C. Harriet Gautamadasa
Published: (2001)

Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?
by: Maria P Rebollo, et al.
Published: (2015)

Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
by: Ramakrishna U Rao, et al.
Published: (2019)

Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
by: Frank O Richards, et al.
Published: (2011)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
by: Chet Raj Ojha, et al.
Published: (2017)

National mass drug administration costs for lymphatic filariasis elimination.
by: Ann S Goldman, et al.
Published: (2007)

The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar.
by: Benjamin F R Dickson, et al.
Published: (2018)

Lymphatic filariasis, infection status in Culex quinquefasciatus and Anopheles species after six rounds of mass drug administration in Masasi District, Tanzania
by: Eliza Lupenza, et al.
Published: (2021)

Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: Current status and future prospects.
by: Nilmini Chandrasena, et al.
Published: (2018)

Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania
by: Adam M. Fimbo, et al.
Published: (2023)

Seroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administration.
by: Colleen L Lau, et al.
Published: (2014)

The impact of the National Programme to Eliminate Lymphatic Filariasis on filariasis morbidity in Sri Lanka: Comparison of current status with retrospective data following the elimination of lymphatic filariasis as a public health problem.
by: Indeewarie E Gunaratna, et al.
Published: (2024)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.
by: Abdullah Alshehri, et al.
Published: (2023)

Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri Lanka.
by: Ramakrishna U Rao, et al.
Published: (2016)

Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019.
by: Gabriela A Willis, et al.
Published: (2023)

Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa.
by: Mark A Schmaedick, et al.
Published: (2014)

Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.
by: Helen J Mayfield, et al.
Published: (2024)

Coverage evaluation of mass drug administration for lymphatic filariasis in Bidar district, Karnataka, India
by: H S Ravish, et al.
Published: (2015)

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.
by: Wilma A Stolk, et al.
Published: (2013)

Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts
by: Prakash Kurubarahalli Patel
Published: (2012)

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.
by: Colleen L Lau, et al.
Published: (2017)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
by: T S Ranganath, et al.
Published: (2012)

Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
by: Dung D Pam, et al.
Published: (2017)

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
by: Alison Krentel, et al.
Published: (2013)

Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.
by: Reza A Niles, et al.
Published: (2021)

Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis.
by: Carmen Maroto-Camino, et al.
Published: (2019)

Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.
by: Daniel J Tisch, et al.
Published: (2011)

Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration
by: Anjali Modi, et al.
Published: (2021)

Contextual determinants of mass drug administration performance: Modelling fourteen years of lymphatic filariasis treatments in West Africa.
by: Brian B Fuller, et al.
Published: (2023)

Correction: Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.
by: Alfred Kwesi Manyeh, et al.
Published: (2021)

Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana.
by: Derrick Adu Mensah, et al.
Published: (2022)

The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya
by: Caroline Kusi, et al.
Published: (2020)

Mass Drug Administration for Lymphatic Filariasis Elimination in Two Districts of North Karnataka: Coverage and Compliance Assessment
by: Huluvadi Shivalingaiah Anwith, et al.
Published: (2020)

Factors associated with never treatment and acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana, 2021.
by: Claudia Duguay, et al.
Published: (2024)

Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
by: Subramanian Swaminathan, et al.
Published: (2012)

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.
by: Paul E Simonsen, et al.
Published: (2010)

An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat
by: Kumar Pradeep, et al.
Published: (2008)